About Biocrates life sciences ag
Biocrates Life Sciences AG: Revolutionizing Metabolomics Analysis
Biocrates Life Sciences AG is a leading provider of ready-to-measure kits and services for quantitative, reproducible, and standardized mass spectrometry-based metabolomics analysis. The company was founded in 2002 by a group of scientists who recognized the need for reliable and accurate metabolomics analysis tools. Since then, Biocrates has been at the forefront of developing innovative solutions that enable researchers to gain deeper insights into metabolic pathways and disease mechanisms.
Metabolomics is an emerging field that involves the comprehensive analysis of small molecules (metabolites) present in biological samples such as blood, urine, or tissue. These molecules are essential intermediates in cellular processes and can provide valuable information about an organism's physiological state. Metabolomics has applications across various fields such as drug discovery, personalized medicine, nutrition research, environmental monitoring, and more.
However, analyzing metabolites is not an easy task due to their diverse chemical properties and low abundance levels. Traditional methods such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS) require extensive sample preparation steps that can introduce variability and bias into the results. Moreover, these methods are time-consuming and require specialized expertise.
This is where Biocrates comes in with its innovative solutions that simplify metabolomics analysis while ensuring accuracy and reproducibility. The company's flagship product line is called AbsoluteIDQ® Kits which are ready-to-use assays for targeted quantification of up to 200 metabolites from various classes such as amino acids, acylcarnitines, glycerophospholipids among others. These kits utilize flow injection analysis-tandem mass spectrometry (FIA-MS/MS) technology which eliminates the need for complex sample preparation steps while providing high-throughput capabilities.
In addition to AbsoluteIDQ® Kits, Biocrates offers a range of services such as metabolomics profiling, biomarker discovery, and validation, customized assay development, and data analysis. The company's team of experts works closely with clients to design tailored solutions that meet their specific research needs. Biocrates has established collaborations with academic institutions, pharmaceutical companies, and clinical research organizations worldwide.
Biocrates' commitment to quality is reflected in its ISO 13485:2016 certification for medical device manufacturing and its compliance with Good Manufacturing Practice (GMP) guidelines. The company's products are CE-marked for in vitro diagnostic use in Europe and have received clearance from the US Food and Drug Administration (FDA) for research use only.
In conclusion, Biocrates Life Sciences AG is a game-changer in the field of metabolomics analysis. Its innovative solutions have simplified the process while ensuring accuracy and reproducibility. With its commitment to quality and customer satisfaction, Biocrates is poised to continue leading the way in this exciting field.
biocrates.com
